Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem
Top Cited Papers
Open Access
- 1 March 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 24 (3) , 543-557
- https://doi.org/10.1359/jbmr.080505
Abstract
Adults with P thalassemia major frequently have low BMD, fractures, and bone pain. The purpose of this study was to determine the prevalence of low BMD, fractures, and bone pain in all thalassemia syndromes in childhood, adolescence, and adulthood, associations of BMD with fractures and bone pain, and etiology of bone disease in thalassemia. Patients of all thalassemia syndromes in the Thalassemia Clinical Research Network, >= 6 yr of age, with no preexisting medical condition affecting bone mass or requiring steroids, participated. We measured spine and femur BMD and whole body BMC by DXA and assessed vertebral abnormalities by morphometric X-ray absorptiometry (MXA). Medical history by interview and review of medical records, physical examinations, and blood and urine collections were performed. Three hundred sixty-one subjects, 49% male, with a mean age of 23.2 yr (range, 6.1-75 yr), were studied. Spine and femur BMD Z-scores < -2 occurred in 46% and 25% of participants, respectively. Greater age, lower weight, hypogonadism, and increased bone turnover were strong independent predictors of low bone mass regardless of thalassemia syndrome. Peak bone mass was Suboptimal. Thirty-six percent of patients had a history of fractures, and 34% reported bone pain. BMD was negatively associated with fractures but not with bone pain. Nine percent of participants had uniformly decreased height of several vertebrae by MXA, which was associated with the use of iron chelator deferoxamine before 6 yr of age. In patients with thalassemia, low BMD and fractures occur frequently and independently of the particular syndrome. Peak bone mass is suboptimal. Low BMD is associated with hypogonadism, increased bone turnover, and an increased risk for fractures.Keywords
This publication has 36 references indexed in Scilit:
- Osteoporosis and InflammationNutrition Reviews, 2008
- Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activationProceedings of the National Academy of Sciences, 2007
- Circulating osteoprotegerin and receptor activator of NF-κB ligand system in patients with β-thalassemia majorJournal of Bone and Mineral Metabolism, 2006
- Association between bone mineral density and erythropoiesis in Thai children and adolescents with thalassemia syndromesJournal of Bone and Mineral Metabolism, 2006
- Osteoporosis in β‐Thalassemia: Clinical and Genetic AspectsAnnals of the New York Academy of Sciences, 2005
- Bone mass and metabolism in thalassemic children and adolescents treated with different iron-chelating drugsJournal of Bone and Mineral Metabolism, 2004
- The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approachesClinical Endocrinology, 1995
- Vertebral fracture assessment using a semiquantitative techniqueJournal of Bone and Mineral Research, 1993
- Prolonged survival in patients with beta-thalassemia major treated with deferoxamineThe Journal of Pediatrics, 1991
- SOME CLINICAL FEATURES OF COOLEY'S ANEMIA PATIENTS AS RELATED TO TRANSFUSION SCHEDULESAnnals of the New York Academy of Sciences, 1969